BR
Bill Rieflin
Individual
William Bill Rieflin is an experienced biotech executive and investor. Former CEO of NGM Biopharmaceuticals and board member at companies like Lyell Immunopharma and RAPT Therapeutics.
Biotech
- Headquarters
- United States
- Total Investments
- 2
- Last Investment
- Nov 2021
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account